scout

Francis Worden, MD

Articles by Francis Worden, MD

Hyunseok Kang, MD, an expert on thyroid cancer

Determining Which DTC Patients May Benefit from Systemic Therapy

ByLori J. Wirth, MD,Francis Worden, MD,Marcia S. Brose, MD, PhD,Daniel Bowles, MD,Hyunseok Kang, MD

Hyunseok Kang, MD, discusses the importance of balancing toxicities and other factors when initiating first-line treatments for patients with refractory differentiated thyroid cancer (DTC), while emphasizing the need to set clear goals and communicate potential adverse reactions before allowing patients to make informed decisions.

Latest Updated Articles